Tehran University of Medical Sciences

Science Communicator Platform

Faculty Members have conducted research related to the Immunogenicity and Safety of Papilloguard® 4, the First Quadrivalent Hpv Vaccine Combined With Adjuvant System 04, Versus Gardasil® in Healthy 15–25-Year-Old Individuals: A Phase Iii, Randomized, Double-Blind, Non-Inferiority Trial
Akram Ghahghaei Nezamabadi
Akram Ghahghaei Nezamabadi

Assistant Professor of Gynecology Oncology

Department Obstetrics and Gynecology

School of Medicine

Arash Hospital

Tehran University of Medical Sciences